Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

600216.SS Net Margin

The Net Margin of Zhejiang Medicine Co Ltd (600216.SS) is 9.83%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

600216.SS Net Margin - Historical Value
Date Value
2025-12-31 9.83%
2024-12-31 12.38%
2023-12-31 5.51%
2022-12-31 6.65%
2021-12-31 11.45%
2020-12-31 9.79%
2019-12-31 4.87%
2018-12-31 5.31%
2017-12-31 4.45%
2016-12-31 8.53%
600216.SS Net Margin - Peers Comparison
Ticker Name Value
600252.SS Guangxi Wuzhou Zhongheng Group Co Ltd -20.42%
603367.SS Cisen Pharmaceutical Co Ltd 12.23%
002390.SZ Guizhou Xinbang Pharmaceutical Co Ltd 2.14%
600329.SS Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd 43.34%
600572.SS Zhejiang CONBA Pharmaceutical Co Ltd 9.55%
000597.SZ Northeast Pharmaceutical Group Co Ltd 3.68%
600812.SS North China Pharmaceutical Co Ltd 1.98%
300158.SZ Shanxi Zhendong Pharmaceutical Co Ltd -44.72%
600557.SS Jiangsu Kanion Pharmaceutical Co Ltd 10.05%
600566.SS Hubei Jumpcan Pharmaceutical Co Ltd 28.59%
603567.SS HeiLongJiang ZBD Pharmaceutical Co Ltd 16.19%
002020.SZ Zhejiang Jingxin Pharmaceutical Co Ltd 17.12%
002435.SZ ChangjiangRunfa Health Industry Co Ltd -23.68%
002755.SZ Beijing Aosaikang Pharmaceutical Co Ltd 9.02%
000650.SZ Renhe Pharmacy Co Ltd 11.83%
000756.SZ Shandong Xinhua Pharmaceutical Co Ltd 3.31%
600195.SS China Animal Husbandry Industry Co Ltd 1.18%
002793.SZ Luoxin Pharmaceuticals Group Stock Co Ltd -36.47%
1666.HK Tong Ren Tang Technologies Co Ltd 6.11%
300026.SZ Tianjin Chase Sun Pharmaceutical Co Ltd 0.37%
600062.SS China Resources Double-Crane Pharmaceutical Co Ltd 14.97%
600422.SS KPC Pharmaceuticals Inc 5.32%
002332.SZ Zhejiang Xianju Pharmaceutical Co Ltd 9.93%
002437.SZ HARBIN GLORIA PHARMACEUTICALS Co Ltd 9.54%
002737.SZ Sunflower Pharmaceutical Group Co Ltd 14.57%
688658.SS Youcare Pharmaceutical Group Co Ltd -10.73%
2096.HK Simcere Pharmaceutical Group Ltd 17.38%
2186.HK Luye Pharma Group Ltd 9.81%